Comprehensive (18)F-FDG PET-based radiomics in elevating the pathological response to neoadjuvant immunochemotherapy for resectable stage III non-small-cell lung cancer: A pilot study

PURPOSE: To develop a comprehensive PET radiomics model to predict the pathological response after neoadjuvant toripalimab with chemotherapy in resectable stage III non-small-cell lung cancer (NSCLC) patients. METHODS: Stage III NSCLC patients who received three cycles of neoadjuvant toripalimab wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Cui, Yingpu, Lin, Yaobin, Zhao, Zerui, Long, Hao, Zheng, Lie, Lin, Xiaoping
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9713843/
https://www.ncbi.nlm.nih.gov/pubmed/36466929
http://dx.doi.org/10.3389/fimmu.2022.994917

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9713843/
https://www.ncbi.nlm.nih.gov/pubmed/36466929
http://dx.doi.org/10.3389/fimmu.2022.994917

Ejemplares similares